Electronic skin sensors prepared from biocompatible and biodegradable polymeric materials significantly benefit the research and scientific community, as they can reduce the amount of effort required for e-waste management by deteriorating or dissolving into the environment without pollution. Herein, we report the use of polylactic acid (PLA)a promising plant-based bioplasticand highly transparent, conductive, biocompatible, and flexible poly­(3,4-ethylenedioxythiophene) polystyrene sulfonate (PEDOT:PSS) materials to fabricate kirigami-based stretchable on-skin electrophysiological sensors via a low-cost and rapid laser cutting technique. The sensor stack with PEDOT:PSS and PLA layers exhibited high transparency (>85%) in the wavelength range of 400–700 nm and stay attached conformally to the skin for several hours without adverse effects. The Y-shaped kirigami motifs inspired by the microcracked gold film endowed the sensor with attributes such as high areal coverage (∼85%), breathability (∼40 g m–2 h–1), and multidirectional stretchability. The sensor has been successfully applied to monitor electrophysiological signals and demonstrated with an eye movement-supported communication interface for controlling home electronic appliances.

BackgroundWhen an out-of-hospital cardiac arrest (OHCA) patient receives cardiopulmonary resuscitation (CPR) in the emergency department (ED), blood laboratory test results can be obtained by using point-of-care testing during CPR. In the present study, the relationship between blood laboratory test results during CPR and outcomes of OHCA patients was investigated.MethodsThis study was a multicenter retrospective analysis of prospective registered data that included 2716 OHCA patients. Data from the EDs of three university hospitals in different areas were collected from January 2009 to December 2014. Univariate and multivariable analyses were conducted to elucidate the factors associated with survival to discharge and neurological outcomes. A final analysis was conducted by including patients who had no prehospital return of spontaneous circulation and those who underwent rapid blood laboratory examination during CPR.ResultsOverall, 2229 OHCA patients were included in the final analysis. Among them, the rate of survival to discharge and a good Cerebral Performance Categories Scale score were 14% and 4.4%, respectively. The pH level was independently related to survival to hospital discharge (adjusted OR 6.287, 95% CI 2.601–15.197; p < 0.001) and good neurological recovery (adjusted OR 15.395, 95% CI 3.439–68.911; p < 0.001). None of the neurologically intact patients had low pH levels (< 6.8) or excessive potassium levels (> 8.5 mEq/L) during CPR.ConclusionsAmong the blood laboratory test results during CPR of OHCA patients, pH and potassium levels were observed as independent factors associated with survival to hospital discharge, and pH level was considered as an independent factor related to neurological recovery.

No abstract

This paper suggests a beat detection method for ballistocardiogram (BCG) from an unconstrained cardiac signal monitoring devices. A fiducial peak point of BCG is an I-J-K complex which corresponds with ventricle contraction and Electrocardiogram (ECG) QRS complex. The goal of the method is extraction of J peak without ECG synchronization. The detection method is based on a "template matching" rule evaluated using a correlation function in a local moving-window procedure. The total beat detection algorithm operates in two stages, template definition stage and beat detection stage with defined template in previous stage. In the first stage, the BCG template is constructed by the expert with an empirical analysis of BCG signal and measurement device. In the second stage, the correlation function calculates an accuracy of template with BCG signal using a local moving-window. The data analysis has been performed on the subjects tested at Seoul National University Hospital Sleep Medicine Center and presents 95.16% of sensitivity and 94.76% of positive predictivity value for the J peak detection.

Objective To test the hypothesis that the quick Sepsis-related Organ Failure Assessment (qSOFA) score, derived from vital signs taken during triage and recommended by current sepsis guidelines for screening patients with infections for organ dysfunction, is not sensitive enough to predict the risk of mortality in emergency department (ED) sepsis patients. Methods Patients diagnosed with severe sepsis and septic shock using the old definition between May 2014 and April 2015 were retrospectively reviewed in three urban tertiary hospital EDs. The sensitivities of systemic inflammatory response syndrome (SIRS) criteria, qSOFA, and Sequential Organ Failure Assessment (SOFA) scores ≥2 were compared using McNemar’s test. Diagnostic performances were evaluated using specificity, positive predictive value, and negative predictive value. Results Among the 928 patients diagnosed with severe sepsis or septic shock using the old definition, 231 (24.9%) died within 28 days. More than half of the sepsis patients (493/928, 53.1%) and more than one-third of the mortality cases (88/231, 38.1%) had a qSOFA score <2. The sensitivity of a qSOFA score ≥2 was 61.9%, which was significantly lower than the sensitivity of SIRS ≥2 (82.7%, P<0.001) and SOFA ≥2 (99.1%, P<0.001). The specificity, positive predictive value, and negative predictive value of a qSOFA score ≥2 for 28-day mortality were 58.1%, 32.9%, and 82.2%, respectively. Conclusion The current clinical criteria of the qSOFA are less sensitive than the SIRS assessment and SOFA to predict 28-day mortality in ED patients with sepsis.

Background Septic shock is a life-threatening condition with underlying circulatory and cellular/metabolic abnormalities. Vitamin C and thiamine are potential candidates for adjunctive therapy; they are expected to improve outcomes based on recent experimental and clinical research. The aim of the Ascorbic Acid and Thiamine Effect in Septic Shock (ATESS) trial is to evaluate the effects of early combination therapy with intravenous vitamin C and thiamine on recovery from organ failure in patients with septic shock. Methods This study is a randomized, double-blind, placebo-controlled, multicentre trial in adult patients with septic shock recruited from six emergency departments in South Korea. Patients will be randomly allocated into the treatment or control group (1:1 ratio), and we will recruit 116 septic shock patients (58 per group). For the treatment group, vitamin C (50 mg/kg) and thiamine (200 mg) will be mixed in 50 ml of 0.9% saline and administered intravenously every 12 h for a total of 48 h. For the placebo group, an identical volume of 0.9% saline will be administered in the same manner. The primary outcome is the delta Sequential Organ Failure Assessment (SOFA) score (ΔSOFA = initial SOFA at enrolment – follow-up SOFA after 72 h). Discussion This trial will provide valuable evidence about the effectiveness of vitamin C and thiamine therapy for septic shock. If effective, this therapy might improve survival and become one of the main therapeutic adjuncts for patients with septic shock. Trial registration ClinicalTrials.gov, NCT03756220 . Registered on 5 December 2018. Electronic supplementary material The online version of this article (10.1186/s13063-019-3542-x) contains supplementary material, which is available to authorized users.

BackgroundHyponatremia is the most common electrolyte imbalance encountered in clinical practice, associated with increased mortality and length of hospital stay. However, no high-quality evidence regarding whether hypertonic saline is best administered as a continuous infusion or a bolus injection has been found to date. Therefore, in the current study, we will evaluate the efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia.Methods/designThis is a prospective, investigator-initiated, multicenter, open-label, randomized controlled study with two experimental therapy groups. A total of 178 patients with severe symptomatic hyponatremia will be enrolled and randomly assigned to receive either rapid intermittent bolus or slow continuous infusion management with hypertonic saline. The primary outcome is the incidence of overcorrection at any given period over 2 days. The secondary outcomes will include the efficacy and safety of two other approaches to the treatment of hyponatremia with 3% hypertonic saline.DiscussionThis is the first clinical trial to investigate the efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe hyponatremia.Trial registrationClinicalTrials.gov, identifier number: NCT02887469. Registered on 1 August 2016.Electronic supplementary materialThe online version of this article (doi:10.1186/s13063-017-1865-z) contains supplementary material, which is available to authorized users.

No abstract